Launch week offerEnds in00h00m00s

annual Promonthly Pro

Anders Ullén

Has grant

Professor of Clinical Oncology

Karolinska Institutet

Sweden

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Sweden Professors in Biostatistics Biostatistics professors in Sweden

Recent Grants

Grant: Close

Predicting response to novel targeted therapies for bladder cancer

Open Date: 2024-01-01

Close Date: 2026-01-01

Grant: Close

Predicting response to novel targeted therapies for bladder cancer.

Open Date: 2022-01-01

Close Date: 2023-01-01

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (16)

Kari Tikkinen

University of Helsinki

FINLAND

View details

Howard Gurney

Macquarie University

AUSTRALIA

View details

Christof Vulsteke

University of Antwerp

BELGIUM

View details

Henrik Kjölhede

Karolinska University Hospital

SWEDEN

View details

Fredrik Liedberg

SWEDEN

View details

Karin Holmsten

Karolinska Institutet

SWEDEN

View details

Johan Lindberg

Karolinska University Hospital

SWEDEN

View details

Brieuc SAUTOIS

Clinical Professor

CHU de Liège - Hôpital du Sart Tilman

BELGIUM

View details

Amir Sherif

Umea University

SWEDEN

View details

Andreas Carus

Aalborg University

DENMARK

View details

Bram De Laere

Karolinska Institutet

SWEDEN

View details

Gottfrid Sjödahl

Lund University

SWEDEN

View details

Päivi Östling

Karolinska Institutet

SWEDEN

View details

Carina Bernardo

Assistant Researcher

Lund University

SWEDEN

View details

Truls Gårdmark

Karolinska Institutet

SWEDEN

View details

Ulf-Göran Gerdtham

Research Director

Lund University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anders Ullén

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (20)

International Survey of Thromboprophylaxis Practices During Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer

Fracture risk and initiation of bone‐specific drug therapy following radical cystectomy with urinary diversion

Application of the International Bladder Cancer Group prediction model for recurrence-free survival on a national cohort of primary intermediate risk non-muscle invasive bladder cancer.

Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer.

Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting

Avelumab first-line maintenance for advanced urothelial carcinoma

Waiting time in diagnosis and extirpative surgery and association with survival and stage progression in upper tract urothelial carcinomas

Swedish national guidelines on urothelial carcinoma: 2024 update on advanced and metastatic disease.

Treatment Related to Urinary Tract Infections Is Associated with Delayed Diagnosis of Urinary Bladder Cancer: A Nationwide Population-based Study.

Exploring novel genomic biomarkers for response and survival after neoadjuvant chemotherapy and radical cystectomy of muscle-invasive bladder cancer

Calendar time trends in synchronous metastatic urinary bladder cancer before and after the introduction of immune checkpoint inhibitors: a nation-wide population-based cohort study

Applicability of the European Association of Urology 2021 Prognostic Model for Non–muscle-invasive Bladder Cancer in a Swedish Population-based Cohort

Lower MeDiC score is associated with non-referral to multidisciplinary team meeting discussion in bladder cancer patients: a nationwide and population-based study.

Risk of upper urinary tract urothelial carcinoma after primary non-muscle-invasive urinary bladder cancer: A nationwide population-based cohort study.

Impact of glucocorticoid treatment and clinical prognostic factors for outcome in patients with advanced urothelial cancer treated with pembrolizumab.

Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial

Diagnostic pathways and treatment strategies in upper tract urothelial carcinoma in Sweden between 2015 and 2021: a population-based survey

Molecular Subtypes Are Associated With Clinical Benefit in Cisplatin-Treated Metastatic Urothelial Cancer Patients

Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience.

Collaborators (16)

Kari Tikkinen

Howard Gurney

Christof Vulsteke

Henrik Kjölhede

Fredrik Liedberg

Karin Holmsten

Johan Lindberg

Brieuc SAUTOIS

Amir Sherif

Andreas Carus

Bram De Laere

Gottfrid Sjödahl

Päivi Östling

Carina Bernardo

Truls Gårdmark

Ulf-Göran Gerdtham

Make your next move.